Xiangya Medical College of Central South University, Changsha, China.
Department of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, China.
Front Cell Infect Microbiol. 2021 Feb 22;11:586427. doi: 10.3389/fcimb.2021.586427. eCollection 2021.
Since the 1950s, gradual changes in the gut microbiota of patients with hepatic encephalopathy have been observed. Previous research has indicated potential associations between the gut and brain, and the gut microbiota is becoming a hot topic in research on diseases of the nervous system. However, for the past few decades, studies of hepatic encephalopathy have been restricted to controlling the gut microbiota during macroscopic manipulation, such as probiotic intervention, while its clinical use remains controversial, and the cellular mechanisms underlying this condition are still poorly understood. This thesis seeks to comprehensively understand and explain the role of gut microbiota in hepatic encephalopathy as well as analyze the effects of intervention by regulating the gut microbiota. Evidence is presented that shows that dysbiosis of the gut microbiota is the primary pathological driver of hepatic encephalopathy and impacts pathologic progression complex regulatory networks. As a result, suggestions were identified for future mechanistic research and improvements in therapeutic strategies for hepatic encephalopathy.
自 20 世纪 50 年代以来,人们观察到肝性脑病患者肠道微生物群逐渐发生变化。之前的研究表明肠道和大脑之间存在潜在联系,而肠道微生物群正成为神经系统疾病研究的热门话题。然而,在过去的几十年里,肝性脑病的研究仅限于在宏观操作过程中控制肠道微生物群,例如益生菌干预,但其临床应用仍存在争议,其潜在的细胞机制仍知之甚少。本论文旨在全面理解和解释肠道微生物群在肝性脑病中的作用,并分析通过调节肠道微生物群进行干预的效果。有证据表明,肠道微生物群失调是肝性脑病的主要病理驱动因素,并影响病理进展的复杂调控网络。因此,为肝性脑病的机制研究和治疗策略的改进提出了建议。